• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤演进模型中的肿瘤内异质性。

Intratumor heterogeneity in evolutionary models of tumor progression.

机构信息

Department of Mathematics, Duke University, Durham, North Carolina 27708, USA.

出版信息

Genetics. 2011 Jun;188(2):461-77. doi: 10.1534/genetics.110.125724. Epub 2011 Mar 15.

DOI:10.1534/genetics.110.125724
PMID:21406679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3122322/
Abstract

With rare exceptions, human tumors arise from single cells that have accumulated the necessary number and types of heritable alterations. Each such cell leads to dysregulated growth and eventually the formation of a tumor. Despite their monoclonal origin, at the time of diagnosis most tumors show a striking amount of intratumor heterogeneity in all measurable phenotypes; such heterogeneity has implications for diagnosis, treatment efficacy, and the identification of drug targets. An understanding of the extent and evolution of intratumor heterogeneity is therefore of direct clinical importance. In this article, we investigate the evolutionary dynamics of heterogeneity arising during exponential expansion of a tumor cell population, in which heritable alterations confer random fitness changes to cells. We obtain analytical estimates for the extent of heterogeneity and quantify the effects of system parameters on this tumor trait. Our work contributes to a mathematical understanding of intratumor heterogeneity and is also applicable to organisms like bacteria, agricultural pests, and other microbes.

摘要

除了极少数例外,人类肿瘤起源于单个细胞,这些细胞积累了必要数量和类型的可遗传改变。每个这样的细胞都会导致失调的生长,最终形成肿瘤。尽管它们具有克隆起源,但在诊断时,大多数肿瘤在所有可测量的表型中都显示出明显的肿瘤内异质性;这种异质性对诊断、治疗效果和药物靶点的识别都有影响。因此,了解肿瘤内异质性的程度和演变具有直接的临床意义。在本文中,我们研究了在肿瘤细胞群体指数增长过程中出现的异质性的进化动态,其中可遗传的改变赋予细胞随机的适应性变化。我们获得了对异质性程度的分析估计,并量化了系统参数对这一肿瘤特征的影响。我们的工作有助于对肿瘤内异质性的数学理解,也适用于细菌、农业害虫和其他微生物等生物体。

相似文献

1
Intratumor heterogeneity in evolutionary models of tumor progression.肿瘤演进模型中的肿瘤内异质性。
Genetics. 2011 Jun;188(2):461-77. doi: 10.1534/genetics.110.125724. Epub 2011 Mar 15.
2
Evolutionary dynamics of intratumor heterogeneity.肿瘤内异质性的进化动态。
PLoS One. 2011 Mar 30;6(3):e17866. doi: 10.1371/journal.pone.0017866.
3
Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.肿瘤内动态异质性和表型可塑性的驱动因素。
Am J Physiol Cell Physiol. 2021 May 1;320(5):C750-C760. doi: 10.1152/ajpcell.00575.2020. Epub 2021 Mar 3.
4
Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival.肿瘤内异质性作为生存预后决定因素的泛癌分析。
Oncotarget. 2016 Mar 1;7(9):10051-63. doi: 10.18632/oncotarget.7067.
5
Intra-tumour heterogeneity - going beyond genetics.肿瘤内异质性——超越遗传学
FEBS J. 2016 Jun;283(12):2245-58. doi: 10.1111/febs.13705. Epub 2016 Apr 1.
6
Variability in the Solid Cancer Cell Population and Its Consequences for Cancer Diagnostics and Treatment.实体癌细胞群体的变异性及其对癌症诊断和治疗的影响。
Klin Onkol. 2018 Winter;31(Suppl 2):5-13. doi: 10.14735/amko20182S5.
7
A Practical Approach to Tumor Heterogeneity in Clinical Research and Diagnostics.临床研究和诊断中肿瘤异质性的实用方法
Pathobiology. 2018;85(1-2):7-17. doi: 10.1159/000477813. Epub 2017 Jul 28.
8
Multiregional Tumor Trees Are Not Phylogenies.多区域肿瘤树并非系统发育树。
Trends Cancer. 2017 Aug;3(8):546-550. doi: 10.1016/j.trecan.2017.06.004. Epub 2017 Jul 17.
9
Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies.单细胞 RNA 测序技术揭示肿瘤功能异质性。
Trends Cancer. 2020 Jan;6(1):13-19. doi: 10.1016/j.trecan.2019.11.010. Epub 2020 Jan 3.
10
Evolution of phenotypic plasticity leads to tumor heterogeneity with implications for therapy.表型可塑性的进化导致肿瘤异质性,这对治疗有影响。
PLoS Comput Biol. 2024 Aug 9;20(8):e1012003. doi: 10.1371/journal.pcbi.1012003. eCollection 2024 Aug.

引用本文的文献

1
Accumulation of Oncogenic Mutations During Progression from Healthy Tissue to Cancer.从健康组织到癌症的进展过程中致癌突变的积累。
Bull Math Biol. 2024 Oct 29;86(12):142. doi: 10.1007/s11538-024-01372-3.
2
Cell Population Growth Kinetics in the Presence of Stochastic Heterogeneity of Cell Phenotype.细胞表型随机异质性存在下的细胞群体生长动力学
ArXiv. 2023 Oct 19:arXiv:2301.03782v2.
3
Role of the Hypoxic-Secretome in Seed and Soil Metastatic Preparation.缺氧分泌组在种子与土壤转移准备中的作用
Cancers (Basel). 2022 Nov 30;14(23):5930. doi: 10.3390/cancers14235930.
4
Chromosomal Instability, Selection and Competition: Factors That Shape the Level of Karyotype Intra-Tumor Heterogeneity.染色体不稳定性、选择与竞争:塑造肿瘤内核型异质性水平的因素
Cancers (Basel). 2022 Oct 12;14(20):4986. doi: 10.3390/cancers14204986.
5
Simulating the Dynamic Intra-Tumor Heterogeneity and Therapeutic Responses.模拟肿瘤内动态异质性和治疗反应。
Cancers (Basel). 2022 Mar 24;14(7):1645. doi: 10.3390/cancers14071645.
6
Delineating the evolutionary dynamics of cancer from theory to reality.描绘癌症从理论到现实的进化动力学。
Nat Cancer. 2020 Jun;1(6):580-588. doi: 10.1038/s43018-020-0079-6. Epub 2020 Jun 22.
7
Centrosome Aberrations as Drivers of Chromosomal Instability in Breast Cancer.中心体异常作为乳腺癌染色体不稳定性的驱动因素。
Endocrinology. 2021 Dec 1;162(12). doi: 10.1210/endocr/bqab208.
8
Grading of endometrial cancer using H HR-MAS NMR-based metabolomics.基于 H HR-MAS NMR 的代谢组学对子宫内膜癌进行分级。
Sci Rep. 2021 Sep 13;11(1):18160. doi: 10.1038/s41598-021-97505-y.
9
Elements and evolutionary determinants of genomic divergence between paired primary and metastatic tumors.配对的原发性和转移性肿瘤之间基因组差异的要素及进化决定因素。
PLoS Comput Biol. 2021 Mar 17;17(3):e1008838. doi: 10.1371/journal.pcbi.1008838. eCollection 2021 Mar.
10
Drivers of dynamic intratumor heterogeneity and phenotypic plasticity.肿瘤内动态异质性和表型可塑性的驱动因素。
Am J Physiol Cell Physiol. 2021 May 1;320(5):C750-C760. doi: 10.1152/ajpcell.00575.2020. Epub 2021 Mar 3.

本文引用的文献

1
Accumulation of driver and passenger mutations during tumor progression.在肿瘤进展过程中积累的驱动突变和乘客突变。
Proc Natl Acad Sci U S A. 2010 Oct 26;107(43):18545-50. doi: 10.1073/pnas.1010978107. Epub 2010 Sep 27.
2
Evolutionary dynamics of tumor progression with random fitness values.具有随机适应度值的肿瘤进展的进化动力学
Theor Popul Biol. 2010 Aug;78(1):54-66. doi: 10.1016/j.tpb.2010.05.001. Epub 2010 May 19.
3
Evolution of resistance and progression to disease during clonal expansion of cancer.癌症克隆扩增过程中耐药性的演变与疾病进展
Theor Popul Biol. 2010 Feb;77(1):42-8. doi: 10.1016/j.tpb.2009.10.008. Epub 2009 Nov 5.
4
Stem cell concepts renew cancer research.干细胞概念革新癌症研究。
Blood. 2008 Dec 15;112(13):4793-807. doi: 10.1182/blood-2008-08-077941.
5
Beneficial fitness effects are not exponential for two viruses.有益的健康效应对于两种病毒而言并非呈指数关系。
J Mol Evol. 2008 Oct;67(4):368-76. doi: 10.1007/s00239-008-9153-x. Epub 2008 Sep 9.
6
The evolution of two mutations during clonal expansion.克隆扩增过程中两个突变的演变。
Genetics. 2007 Dec;177(4):2209-21. doi: 10.1534/genetics.107.078915.
7
Genetic progression and the waiting time to cancer.基因进展与患癌等待时间。
PLoS Comput Biol. 2007 Nov;3(11):e225. doi: 10.1371/journal.pcbi.0030225.
8
Clonal interference in large populations.大群体中的克隆干扰。
Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18135-40. doi: 10.1073/pnas.0705778104. Epub 2007 Nov 5.
9
Breast tumor heterogeneity: cancer stem cells or clonal evolution?乳腺肿瘤异质性:癌症干细胞还是克隆进化?
Cell Cycle. 2007 Oct 1;6(19):2332-8. doi: 10.4161/cc.6.19.4914. Epub 2007 Aug 17.
10
Molecular definition of breast tumor heterogeneity.乳腺肿瘤异质性的分子定义。
Cancer Cell. 2007 Mar;11(3):259-73. doi: 10.1016/j.ccr.2007.01.013.